Centre to pick out locations for bulk drug, medical device parksIllustrative image – not actual.
The Central government is finalising guidelines for selection of locations of upcoming bulk drug and medical device parks in the country.

The Department of Pharmaceuticals is finalising guidelines which will form the basis for objectively selecting locations of the upcoming three bulk drugs parks and four medical devices parks in the country.

The Union Cabinet on 12 March 2020 had approved scheme for development of three bulk drugs and four medical device parks, in which the government will extend grants-in-aid to states with a maximum limit of Rs 1,000 crore per bulk drugs park and Rs 100 crore per medical device parks.

This is being done in order to encourage domestic production of critical active pharmaceutical ingredients (APIs)/ key starting material (KSM) and medical devices.

The government also announced a production-linked incentive (PLI) scheme for promoting domestic manufacturing of key critical starting materials/drug intermediates and APIs and medical devices across the country.

The total financial implications of these schemes will be about Rs 13,760 crore.

The scheme for promotion of bulk drugs park is expected to result in incremental production of bulk drugs worth about Rs 46,400 crore, while the scheme for promotion of medical device park will lead to incremental production of medical devices worth about Rs 68,437 crore.

These schemes will also result in significant generation of jobs.

The development of these parks will not only reduce the country's dependence on imports, but will also be helpful in making India a major player in global pharma exports.

← All latest storiesBack to top →